Stock Report

Download full stock data and analysis for free Last Updated: 27-Aug-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Sterling Biotech Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: STERLINBIO | BSE: 512299

₹0.70

₹0.00 (0.00%)

As on 05-Nov-2018IST

Market cap

info icon

₹21 Cr

Revenue (TTM)

info icon

₹457 Cr

P/E Ratio

info icon

--

P/B Ratio

info icon

-0

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 15.85 8.38 5.20 -- --
EBIT -2.23 12.89 151.22 -- --
Net Profit 127.16 122.00 -100.32 -- --
EPS 127.15 122.00 -100.32 -- --
Book Value -- -- -2.15 -- --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsMar-24Mar-23Mar-22
EBIT-Margin info ----11.14-22.89-71.32
Net Margin info -----4.051,347.88-71.25
Return on equity info -----2.170.000.00
Return on Capital info -----0.70385.79-5.70
Return on Assets info -----3.07477.82-6.60
Debt to Equity (x) info ----0.010.00-1.41

Profitability

View Detailed Peer Comparison

ROCE

-0.70

Lower than Peers by 15.41

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Mar-24
Mar-23
Mar-22
Mar-18
Mar-17
Sterling Biotech
-0.70
385.79
-5.70
-12.49
-3.00
Peer Median
14.72
18.85
11.60
15.21
--
ROE

-2.17

Lower than Peers by 13.84

Profit after tax / Average Net worth * 100

Company Name
Mar-24
Mar-23
Mar-22
Mar-18
Mar-17
Sterling Biotech
-2.17
--
--
-129.56
-28.06
Peer Median
11.67
14.92
11.46
9.89
--
ROA

-3.07

Lower than Peers by 10.93

Profit after tax / Average Total assets * 100

Company Name
Mar-24
Mar-23
Mar-22
Mar-18
Mar-17
Sterling Biotech
-3.07
477.82
-6.60
-13.37
-5.11
Peer Median
7.86
9.06
6.44
5.28
--
EBIT Margin

11.14

Lower than Peers by 3.89

Operating profit (EBIT) / Net Sales * 100

Company Name
Mar-24
Mar-23
Mar-22
Mar-18
Mar-17
Sterling Biotech
11.14
-22.89
-71.32
-65.75
-68.12
Peer Median
15.03
14.71
12.37
14.68
--
Net Margin

-4.05

Lower than Peers by 13.37

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Mar-24
Mar-23
Mar-22
Mar-18
Mar-17
Sterling Biotech
-4.05
1,347.88
-71.25
-280.96
-110.76
Peer Median
9.33
8.49
10.02
9.44
--
Cash Profit Margin

-0.88

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
Mar-24
Mar-23
Mar-22
Mar-18
Mar-17
Sterling Biotech
-0.88
1,415.51
-12.78
-211.17
-37.21
Peer Median
--
--
--
--
--

Growth

View Detailed Peer Comparison

Revenue Growth

5.20

Lower than Peers by 5.07

Year on year growth in net sales

Company Name
Mar-24
Mar-23
Mar-22
Mar-18
Mar-17
Sterling Biotech
5.20
5.95
16.33
-4.37
-29.69
Peer Median
10.27
11.85
9.08
8.37
--
EBIT Growth

151.22

Higher than Peers by 127.07

Year on year growth in operating profit (EBIT)

Company Name
Mar-24
Mar-23
Mar-22
Mar-18
Mar-17
Sterling Biotech
151.22
65.99
--
7.70
10.59
Peer Median
24.15
28.00
-3.12
22.09
--
Net Profit Growth

-100.32

Lower than Peers by 130.61

Year on year growth in profit after tax

Company Name
Mar-24
Mar-23
Mar-22
Mar-18
Mar-17
Sterling Biotech
-100.32
2,128.49
70.64
-143.76
8.44
Peer Median
30.29
36.51
-0.85
9.35
--
EPS Growth

-100.32

Lower than Peers by 124.82

Year on year growth in earnings per share

Company Name
Mar-24
Mar-23
Mar-22
Mar-18
Mar-17
Sterling Biotech
-100.32
185.82
70.64
-143.76
8.44
Peer Median
24.50
--
-6.82
5.26
--
Book Value Growth

-2.14

--

Year on year growth in book value per share

Company Name
Mar-24
Mar-23
Mar-22
Mar-18
Mar-17
Sterling Biotech
-2.14
115.68
-2,178.11
-78.38
-23.30
Peer Median
--
--
--
--
--

Solvency

View Detailed Peer Comparison

Debt to Equity

0.01

Lower than Peers by 0.22

Total debt / Net worth

Company Name
Mar-24
Mar-23
Mar-22
Mar-18
Mar-17
Sterling Biotech
0.01
--
-1.41
27.16
5.45
Peer Median
0.23
0.20
0.15
0.29
--
Short term debt to equity ratio

0.01

--

(Short term borrowings / Net worth)

Company Name
Mar-24
Mar-23
Mar-22
Mar-18
Mar-17
Sterling Biotech
0.01
--
-0.22
4.39
0.75
Peer Median
--
--
--
--
--
Current Ratio

7.72

Higher than Peers by 5.93

Current Assets / Current Liabilities and Provisions

Company Name
Mar-24
Mar-23
Mar-22
Mar-18
Mar-17
Sterling Biotech
7.72
10.97
0.26
0.09
0.35
Peer Median
1.79
1.96
2.08
1.68
--
Quick Ratio

5.36

Higher than Peers by 3.90

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Mar-24
Mar-23
Mar-22
Mar-18
Mar-17
Sterling Biotech
5.36
7.70
0.19
0.07
0.12
Peer Median
1.47
1.44
1.58
1.25
--
Interest Coverage

-8.68

Lower than Peers by 18.10

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Mar-24
Mar-23
Mar-22
Mar-18
Mar-17
Sterling Biotech
-8.68
--
-139.69
-2.27
-0.67
Peer Median
9.42
8.58
15.41
10.92
--

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

11.53

Lower than Peers by 14.29

Debtors outstanding / Net Sales * 100

Company Name
Mar-24
Mar-23
Mar-22
Mar-18
Mar-17
Sterling Biotech
11.53
11.51
8.76
14.57
11.76
Peer Median
25.82
26.12
22.96
23.15
--
Asset Turnover

0.73

Lower than Peers by 0.02

Sales / Average Total Assets

Company Name
Mar-24
Mar-23
Mar-22
Mar-18
Mar-17
Sterling Biotech
0.73
0.35
0.09
0.05
0.05
Peer Median
0.75
0.77
0.65
0.73
--
Receivable days

41.01

--

Average Debtors / Sales * 365

Company Name
Mar-24
Mar-23
Mar-22
Mar-18
Mar-17
Sterling Biotech
41.01
36.09
38.84
48.03
39.03
Peer Median
--
--
--
--
--
Inventory Days

87.13

--

Average Inventory / Sales * 365

Company Name
Mar-24
Mar-23
Mar-22
Mar-18
Mar-17
Sterling Biotech
87.13
79.02
68.28
387.72
647.95
Peer Median
--
--
--
--
--
Payable days

58.31

--

Average Creditors / Cost of goods sold * 365

Company Name
Mar-24
Mar-23
Mar-22
Mar-18
Mar-17
Sterling Biotech
58.31
46.71
42.79
42.52
40.20
Peer Median
--
--
--
--
--
Cash Conversion Cycle

69.82

--

Receivable Days + Inventory Days - Payable Days

Company Name
Mar-24
Mar-23
Mar-22
Mar-18
Mar-17
Sterling Biotech
69.82
68.41
64.34
393.22
646.78
Peer Median
--
--
--
--
--

Valuation

View Detailed Peer Comparison

Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
Mar-24
Mar-23
Mar-22
Mar-18
Mar-17
Sterling Biotech
--
--
--
--
--
Peer Median
39.70
33.48
37.74
31.85
--
Price / Book Value

--

--

Current share price divided by book value per share in the latest financial year

Company Name
Mar-24
Mar-23
Mar-22
Mar-18
Mar-17
Sterling Biotech
--
--
--
0.16
0.09
Peer Median
3.72
4.21
3.22
2.93
--
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
Mar-24
Mar-23
Mar-22
Mar-18
Mar-17
Sterling Biotech
--
--
--
--
--
Peer Median
0.16
0.21
0.57
0.56
--
EV/EBITDA

5.25

Lower than Peers by 24.98

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Mar-24
Mar-23
Mar-22
Mar-18
Mar-17
Sterling Biotech
5.25
6.95
-175.33
383.95
425.92
Peer Median
30.23
29.90
28.81
23.55
--
Market Cap

--

--

Current Share price multiplied by latest total number of shares outstanding

Company Name
Mar-24
Mar-23
Mar-22
Mar-18
Mar-17
Sterling Biotech
--
--
--
45
117
Peer Median
4,851
2,099
15,272
10,579
--
loading...
loading...
loading...